Precision BioSciences, Inc.
DTIL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $7,167 | -$61,319 | -$111,637 | -$30,602 |
| Dep. & Amort. | $4,577 | $8,255 | $9,004 | $10,197 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $12,604 | $14,040 | $19,197 | $16,514 |
| Change in WC | -$53,999 | -$41,487 | $24,110 | $19,584 |
| Other Non-Cash | -$28,794 | -$3,603 | $13,573 | -$26,546 |
| Operating Cash Flow | -$58,445 | -$84,114 | -$45,753 | -$10,853 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$250 | -$2,278 | -$3,319 | -$5,053 |
| Net Acquisitions | $60 | $8,000 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$25 | $107 | $0 | -$750 |
| Investing Cash Flow | -$215 | $5,829 | -$3,319 | -$5,803 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$37 | $0 | $19,805 | $2,470 |
| Stock Issued | $50,238 | $4,986 | $74,345 | $60,477 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $249 | $401 | $835 | $7,574 |
| Financing Cash Flow | $50,450 | $5,387 | $94,985 | $70,521 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$8,210 | -$72,898 | $45,913 | $53,865 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $116,678 | $189,576 | $143,663 | $89,798 |
| End Cash | $108,468 | $116,678 | $189,576 | $143,663 |
| Free Cash Flow | -$58,695 | -$86,392 | -$49,072 | -$16,656 |